Quarterly Newsletter of the NIH Rare Diseases Clinical Research Network
December 2010

www.RareDiseasesNetwork.org

In This Issue

Introducing Spotlight on Rare Diseases

The NIH Rare Diseases Clinical Research Network (RDCRN) Doubles in Size

Message from Alan Percy, RDCRN Steering Committee Chair

About Spotlight

Current Issue of Spotlight

Network News and Events

World Rare Disease Day
February 28, 2011
rarediseaseday.us

7th Annual World Symposium, Research for Lysosomal Diseases
February 16-18, 2011

5th International Dystonia Symposium
Barcelona, Spain
October 20-22 2011

Featured Event:

2nd Annual Conference on Clinical Research for Rare Diseases (CCRRD) >> More

Rare Diseases Headlines:

President Signs "Improving Access to Clinical Trials Act" into law
>> More

CTSA Consortium to Enhance Support of Rare Diseases Research
>> More

IOM Releases Report on Accelerating Rare Diseases Research
>> More

Do you have thoughts about this eNewsletter? We want to hear from you.

Send comments to RDNWebmaster@epi.usf.edu

2nd Conference on Clinical Research for Rare Diseases

The Rare Diseases Clinical Research Network (RDCRN) and the Clinical and Translational Science Awards (CTSA) programs co-sponsored the 2nd Conference on Clinical Research for Rare Diseases (CCRRD) which was held in September 2010 in Bethesda, Maryland. The Conference was again planned and organized by Dr. Peter Merkel of the Boston University School of Medicine. This unique conference focused on research methodology for rare diseases and with a particular emphasis on helpful information for trainees and junior faculty engaged in such research. There were 270 meeting attendees, including trainees, junior and senior faculty, NIH program officials, and leaders of patient advocacy groups.


Peter Merkel, MD
Principal Investigator of
the Vasculitis Clinical
Research Consortium;
Professor of Medicine
Section of Rheumatology
and the Clinical
Epidemiology Unit;
Director, Vasculitis Center

Among the conference speakers were investigators from the RDCRN and CTSA program, and representatives of the US FDA, the biomedical industry, and patient advocacy groups. Topics covered included creating research networks for rare diseases, design issues for clinical trials of small sample sizes, pathways to FDA approval of orphan drugs, partnering on rare disease research with the pharmaceutical industry, utilizing the resources of the CTSAs, understanding unique issues of conflict of interest in rare disease research, and the challenges and opportunities involved in developing an academic career studying rare diseases. Over 90 scientific posters were presented and award-winning abstracts were presented in a plenary session. The conference ended with a lecture by Mr. John Crowley, whose account of his successful professional efforts to promote the development of a therapy to treat Pompe disease, which affects two of his children, was inspirational for all attendees.

The CCRRD was supported by generous grants from the following NIH offices/institutes: ORDR, NINDS, NCRR, NIAID, and NICHD. Additional support for trainees was provided by several patient advocacy groups.

The Conference on Clinical Research for Rare Diseases was a great success. Plans are underway for CCRRD 2012.

The presentations from the meeting will soon be made available to the public via internet through the CCRRD Web Site.